Aptevo Therapeutics Inc.APVONASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank9
3Y CAGR-10.4%
5Y CAGR-8.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-10.4%/yr
vs -14.7%/yr prior
5Y CAGR
-8.9%/yr
Consistent
Acceleration
+4.3pp
Accelerating
Percentile
P9
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $24.25M | -16.0% |
| 2023 | $28.88M | -9.1% |
| 2022 | $31.75M | -5.7% |
| 2021 | $33.69M | +141.5% |
| 2020 | $13.95M | -64.0% |
| 2019 | $38.73M | -39.0% |
| 2018 | $63.52M | -0.1% |
| 2017 | $63.60M | -6.7% |
| 2016 | $68.18M | -12.3% |
| 2015 | $77.77M | - |